Aliada Therapeutics logo

Aliada Therapeutics

Beyond boundaries: Crossing the blood-brain barrier to create the next generation of central nervous system therapies

26 employees · est. 2021 · Boston, United States

VS
ICB International logo

ICB International

Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS diseases like neurodegeneration, cancer, and infections.

est. 2008

ICB International is the older company (2021 vs 2008).

Side-by-Side Comparison

Aliada Therapeutics ICB International
Founded
2021 2008 older
Headquarters
Boston, United States Not tracked yet
Employees
26 Not tracked yet
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Series Unknown Series Unknown
Total Funding
$32.00M $895.00K
Funding Rounds
1 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biologics, CNS Drug Development, Blood-brain Barrier Crossing, Therapeutic Antibodies, NHP Proof Of Concept, Oligonucleotide Delivery, Central Nervous System Therapies, Preclinical Evaluation, Platform Technology, Enzyme Therapy, Customizable Delivery Technology Non-invasive Diagnostics, Therapeutics, CNS Diseases, Neurodegeneration, Cancer Treatment, Infectious Diseases, Blood-brain Barrier Technology, Immunology, Biomedicine, FDA Approval, Central Nervous System, Platform Technology, Proprietary Technology, California Biosciences International
Website
aliadatx.com icbii.com
Aliada Therapeutics logo

About Aliada Therapeutics

Aliada Therapeutics is a biotechnology startup that aims to revolutionize the treatment of central nervous system (CNS) diseases by overcoming the challenge of crossing the blood-brain barrier. With the slogan "Beyond boundaries: Crossing the blood-brain barrier to create the next generation of cent...

ICB International logo

About ICB International

ICB International is a biotechnology and healthcare startup that has been pioneering breakthrough technology in the field of non-invasive diagnostics and therapeutics for CNS diseases. Established in 2008, the company's unique blood-brain barrier permeable technology is at the forefront of addressin...

We will tell you when either one moves

BounceWatch watches Aliada Therapeutics and ICB International for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aliada Therapeutics and ICB International — by email.

Frequently Asked Questions

Aliada Therapeutics — Beyond boundaries: Crossing the blood-brain barrier to create the next generation of central nervous system therapies. ICB International — Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS diseases like neurodegeneration, cancer, and infections.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aliada Therapeutics has raised $32.00M while ICB International has raised $895.00K.
Aliada Therapeutics and ICB International operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aliada Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aliada Therapeutics on 4 Dec 2024, and ICB International on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy